" /> Myoclonic epilepsy of unverricht and lundborg - CISMeF





Preferred Label : Myoclonic epilepsy of unverricht and lundborg;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : ULD; EPM1; Epilepsy, progressive myoclonic, 1a; Progressive myoclonic epilepsy; EPM1A; Baltic myoclonic epilepsy; PME; Epilepsy, progressive myoclonic, 1;

Description : Myoclonic epilepsy of Unverricht and Lundborg is an autosomal recessive disorder characterized by onset of neurodegeneration between 6 and 13 years of age. Although it is considered a progressive myoclonic epilepsy, it differs from other forms in that is appears to be progressive only in adolescence, with dramatic worsening of myoclonus and ataxia in the first 6 years after onset. The disease stabilizes in early adulthood, and myoclonus and ataxia may even improve, and there is minimal to no cognitive decline (summary by Ramachandran et al., 2009). - Genetic Heterogeneity of Progressive Myoclonic Epilepsy Progressive myoclonic epilepsy refers to a clinically and genetically heterogeneous group of neurodegenerative disorders, usually with debilitating symptoms, although severity varies. See also EPM1B (612437), caused by mutation in the PRICKLE1 gene (608500); Lafora disease (EPM2A/B; 254780), caused by mutation in either the EPM2A (607566) or the NHLRC1 (608072) gene; EPM3 (611726), caused by mutation in the KCTD7 gene (611725); EPM4 (254900), caused by mutation in the;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the cystatin B gene (CSTB, 601145.0001);

Prefixed ID : #254800;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.